U.S. Software Stock News

CoStar Group FY 2025 results: revenue climbs while profitability tightens CoStar Group (CSGP) has wrapped up FY 2025 with Q4 revenue of US$900 million and basic EPS of US$0.11, setting the tone for a year where top line growth led the story while profitability stayed slim. Over the past six quarters, revenue has moved from US$692.6 million in Q3 2024 to US$900 million in Q4 2025, while quarterly basic EPS has swung between a loss of US$0.07 in Q3 2025 and a high of US$0.15 in Q4 2024. This...

Ionis Pharmaceuticals FY 2025 earnings snapshot Ionis Pharmaceuticals (IONS) closed FY 2025 with fourth quarter revenue of US$203 million and a basic EPS loss of US$1.41, alongside a trailing twelve month revenue base of US$944 million and a TTM basic EPS loss of US$2.38. Over the past year, quarterly revenue has moved between US$131.6 million and US$452.0 million, while basic EPS swung from a profit of US$0.78 in Q2 2025 to losses of US$0.93 in Q1 and US$0.80 in Q3. This sets up a results...

Mirion Technologies (NYSE:MIR) is facing material trade policy uncertainty after the US administration imposed new 15% global tariffs under the Trade Act of 1974. The tariffs follow a recent Supreme Court ruling and are being implemented abruptly, affecting companies with international supply chains. For Mirion, the policy shift raises questions around cost structure, operational planning, and future financial results. Mirion Technologies, trading at $21.49, now sits at the center of a...

In February 2026, Select Medical Holdings Corporation reported mixed fourth-quarter and full-year 2025 results, with revenue rising to US$1,396.63 million for the quarter and US$5,452.83 million for the year, while profitability remained under pressure. On the same day, the company declared a US$0.0625 per-share cash dividend and issued 2026 guidance calling for US$5.6 billion to US$5.8 billion in revenue and fully diluted earnings per share of US$1.22 to US$1.32, framing how management sees...

Expro Group Holdings (NYSE:XPRO) has authorized a new $100 million share repurchase program. The company has secured a major multi-year contract in North Africa with an initial four-year term. Recent earnings included higher margins and free cash flow, alongside softer revenue in certain regions. Expro Group, a global energy services provider listed on the NYSE as XPRO, is active across well construction, well flow management, and subsea services. The mix of a sizable buyback authorization...

Corcept Therapeutics FY 2025 earnings snapshot Corcept Therapeutics (CORT) has wrapped up FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.24, alongside net income of US$25.4 million. Over the past six quarters, the company has seen revenue move from US$181.9 million in Q4 2024 to a range between US$157.2 million and US$207.6 million per quarter, while basic EPS has ranged between US$0.19 and US$0.45. With a trailing 12 month net profit margin of 13.1% compared to 20.7% a...

McDonald's (MCD) closed out FY 2025 with fourth quarter revenue of US$7.0 billion and basic EPS of US$3.03, alongside net income of US$2,164 million, setting the tone for a year where trailing 12 month revenue reached US$26.9 billion and EPS came in at US$12.00. Over the past few quarters, revenue has moved from US$5,956 million in Q1 2025 to US$7,078 million in Q3 2025 before landing at US$7,009 million in Q4. Quarterly EPS ranged between US$2.61 and just over US$3.19, with a trailing net...

Trinity Capital (TRIN) closed out FY 2025 with Q4 total revenue of US$77.6 million and basic EPS of US$0.51, alongside trailing twelve month revenue of US$279.5 million and EPS of US$1.96, set against reported earnings growth of 17.3% over the past year. Over recent periods the company has seen revenue move from US$205.2 million on a trailing basis in Q3 2024 to US$226.7 million in Q4 2024 and then to US$279.5 million by Q4 2025. Trailing EPS shifted from US$1.79 to US$2.19 and then to...

Ameris Bancorp recently announced that Corporate Executive Vice President and Chief Strategy Officer James A. LaHaise will retire on April 30, 2026, with a three-month transition period and retirement benefits under an existing supplemental plan. His departure, alongside the earlier-disclosed retirement of Chief Risk Officer Bill McKendry and internal promotions to fill these roles, highlights an important refresh of Ameris’s leadership bench in strategy, risk, and oversight functions. We’ll...

Gulfport Energy (GPOR) has wrapped up FY 2025 with fourth quarter revenue of US$355.5 million and basic EPS of US$6.90, alongside net income excluding extra items of US$132.4 million. Over the past year, revenue on a trailing 12 month basis has moved from US$909.2 million in Q4 2024 to US$1.3 billion in Q4 2025, while basic EPS over the same window shifted from a loss of US$14.72 to a profit of US$21.74. This sets up a year in which margins and cash generation are front and center for...

If you are wondering whether Howard Hughes Holdings is starting to look like value at today's price, or if the market still sees it as a work in progress, this article will walk you through what the numbers are really saying. Despite trading at US$72.77, the stock has seen recent pressure, with returns of a 12.4% decline over 7 days, a 10.2% decline over 30 days, a 7.7% decline year to date and a 1.8% decline over the past year, extending to a 7.5% decline over 3 years and an 18.4% decline...

United Therapeutics (UTHR) FY 2025 Earnings Snapshot United Therapeutics (UTHR) closed FY 2025 with fourth quarter revenue of US$790.2 million and basic EPS of US$8.41, capping a twelve month run where trailing revenue reached US$3.2 billion and EPS came in at US$30.13. Over that period, revenue has moved from US$2.9 billion to US$3.2 billion and EPS has shifted from US$26.44 to US$30.13, giving investors a clear view of how the top line and EPS have tracked together. With a net income of...

Pebblebrook Hotel Trust (NYSE:PEB) recently completed a $450 million senior unsecured term loan. The company used part of the proceeds to repay certain mortgages and address near term debt maturities. Management also restored full capacity on its revolving credit facility, increasing available liquidity. Pebblebrook Hotel Trust, trading at $12.24, has had mixed share performance, with a 6.0% return year to date and a 4.6% return over the past year, but weaker 3 year and 5 year returns of...

If you are wondering whether Perfect's current share price reflects its true worth, this breakdown will help you connect the recent market action to what the numbers actually say about value. Perfect's share price closed at US$1.38, with returns of a 5.5% decline over 7 days, a 17.4% decline over 30 days, a 20.2% decline year to date, a 27.7% decline over 1 year and 81.9% and 86.1% declines over 3 and 5 years. This performance sits against a backdrop of ongoing market attention on software...

Matador Resources (MTDR) has wrapped up FY 2025 with fourth quarter revenue of US$848 million and basic EPS of US$1.55, alongside net income excluding extra items of US$192.5 million. This gives investors a clear read on its latest run rate. Over the past year, total revenue on a trailing twelve month basis has moved from US$3.24 billion in Q4 2024 to US$3.70 billion in Q4 2025, while trailing basic EPS shifted from US$7.16 to US$6.10, framing the current quarter against a fuller year of...

MGP Ingredients (MGPI) FY 2025 earnings snapshot MGP Ingredients (MGPI) has just wrapped up FY 2025 with fourth quarter revenue of US$138.3 million, Basic EPS of US$6.22 loss, and a net income loss excluding extra items of US$133.0 million. Over the past few quarters, the company has seen revenue move from US$161.5 million in Q3 FY 2024 to US$130.9 million in Q3 FY 2025 and EPS shift from US$1.07 in Q3 FY 2024 to US$0.71 in Q3 FY 2025, while trailing twelve month EPS moved from US$1.56 in Q4...

ONEOK (NYSE:OKE) reported double digit net income and adjusted EBITDA growth for 2025. The company exceeded synergy targets from recent acquisitions, including Magellan, and retired a significant amount of long term debt. ONEOK raised its quarterly dividend by 4% and continued integrating acquired assets through 2025. Management outlined plans for 2026 that include expansion into fee based earnings and energy solutions for data centers. ONEOK is a large midstream operator focused on natural...

If you are wondering whether Navios Maritime Partners is still attractively priced or already reflecting a lot of optimism, this article is here to break that question down into plain terms. The stock last closed at US$68.11, with returns of 5.5% over 7 days, 17.2% over 30 days, 32.5% year to date and 60.3% over the past year. That performance is likely to catch the eye of investors thinking about growth potential and changing risk perceptions. Recent news coverage around Navios Maritime...

Matson (MATX) has wrapped up FY 2025 with fourth quarter revenue of US$851.9 million and basic EPS of US$4.65, alongside full year trailing twelve month revenue of about US$3.3 billion and EPS of US$13.99. Over the past six reported quarters, revenue has moved between US$782 million and US$962 million, while quarterly EPS has ranged from US$2.20 to US$5.98, giving investors a clear view of how trading conditions have flowed through to the bottom line. With a trailing net margin of 13.3% and...

Circle Internet Group (CRCL) just posted its FY 2025 Q4 numbers, with revenue of US$770.2 million and basic EPS of US$0.56, against a trailing twelve month revenue base of US$2.7 billion and basic EPS of US$0.44 loss. The company has seen quarterly revenue move from US$435.4 million in Q4 2024 to US$770.2 million in Q4 2025. Basic EPS shifted from US$0.08 in Q4 2024 through a volatile FY 2025 that included a US$4.48 loss in Q2 before settling at US$0.56 in Q4. This sets the stage for...

BioMarin Pharmaceutical has entered into a definitive agreement to acquire Amicus Therapeutics. The deal marks a major change for Amicus Therapeutics and its commercial portfolio. The transaction is viewed as a material event for shareholders and the wider biotechnology sector. For investors watching Amicus Therapeutics, NasdaqGM:FOLD, the new acquisition agreement with BioMarin comes at a time when the stock is trading at $14.34. Over the past year, the share price return of 58.8% and...

Hippo Holdings FY 2025 Earnings: Profitability Backdrop Comes Into Focus Hippo Holdings (HIPO) has wrapped up FY 2025 with fourth quarter revenue of US$119.4 million, basic EPS of US$0.24 and net income of US$6 million, against a backdrop where trailing twelve month EPS sits at US$2.28 on revenue of US$467.6 million and net income of US$57.7 million. Over recent periods, the company has seen revenue move from US$101.9 million in Q4 2024 to US$119.4 million in Q4 2025, while quarterly basic...

Camping World Holdings FY 2025 Earnings Snapshot Camping World Holdings (CWH) has wrapped up FY 2025 with fourth quarter revenue of US$1.2 billion and a basic EPS loss of US$1.07, while trailing twelve month revenue came in at US$6.4 billion with a full year basic EPS loss of US$1.43. Over recent quarters the company has seen quarterly revenue range from US$1.4 billion to US$2.0 billion, with basic EPS moving from a profit of US$0.48 in Q2 2025 to losses in Q1, Q3 and Q4. This sets up a mixed...

Stanley Black & Decker (SWK) closed out FY 2025 with Q4 revenue of US$3.7b and basic EPS of US$1.04 on net income of US$158.2m, setting the tone for how investors will read the full year. Over recent quarters, revenue has moved in a tight band between US$3.7b and US$3.9b, while quarterly EPS has ranged from US$0.34 to US$1.04, with trailing twelve month EPS at US$2.66 on revenue of US$15.1b. As a result, the focus now is on how efficiently those sales are turning into profit and what that...